Application deadline: 28/02/2019
Number of vacancies: 1
A Post-Doctoral position is available at the Vall d’Hebron Institute of Oncology’s (VHIO) Experimental Hematology Group. Our group, directed by Dr. Francesc Bosch, head of the Hematology Department at Vall d’Hebron University Hospital, focuses on the study of the mechanisms of pathogenesis and progression of hematologic malignancies. We seek an enthusiastic postdoctoral research scientist with a strong background in hematology and/or immunology. The research project centers on the role of the innate immune system in lymphomas involving the central nervous system using in vivo models including patient-derived xenografts, and is fully financed for three years.
To discover more about our group please visit: http://www.vhio.net/en/experimental-hematology-group/
- Scientific background in the hematology and/or immunology fields.
- Accreditation and experience working with research animals.
- Minimum level of English: C1.
- The candidate must be proficient in the preparation of manuscripts for publication in peer-reviewed international scientific journals.
- The successful candidate will be organized, motivated and team-oriented with experience working in a translational research laboratory, ideally with previous experience in cancer research.
- He/she will be expected to design and execute experimental plans aligned with the overall aims of the research project, and will also be involved in mentoring younger scientists.
- Previous experience as a postdoctoral researcher will be favorably considered.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), created by José Baselga in 2007, has established itself as a comprehensive cancer centre of proven excellence internationally. It is thanks to Josep Tabernero´s directorship and VHIO´s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO´s pioneering model and programes, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO´s translation toward precision oncology: http://www.vhio.net.
Application: Please send your CV and cover letter highlighting your scientific interests using the form or via email to: email@example.com, adding “Ref. 17/2018” in the subject line.